XPEL, Inc. (XPEL) Market Cap & Valuation Ratios
XPEL, Inc. (XPEL) has a market cap of $1.2B, a trailing P/E of 21.9 and a price-to-sales ratio of 2.3, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
XPELXPEL, Inc.Follow XPEL — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- 21.9
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Peers
auto parts · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| XPEL | 1.2 | 21.9 | 2.3 | 14.3 | -0.2% | +13% | 13% | 18% |
| PHIN | 2.1 | 16.5 | 0.8 | 6.6 | 11.9% | +8% | 7% | 8% |
| VC | 1.9 | 13.2 | 0.5 | 5.4 | 8.5% | +2% | 5% | 15% |
| THRM | 1.5 | 98.6 | 1.0 | 14.0 | 1.3% | +9% | 3% | 4% |
| ADNT | 1.3 | 30.2 | 0.2 | 3.6 | 23.0% | +5% | 3% | 7% |
| GT | 1.2 | — | 0.4 | 15.6 | 15.6% | -4% | -3% | -5% |
| DCH | 1.1 | — | 0.6 | 7.4 | -2.8% | +41% | 1.0% | 1% |
| PLOW | 0.9 | 18.1 | 1.6 | 11.8 | 5.3% | +20% | 11% | 13% |
| SMP | 0.8 | 16.6 | 0.7 | 6.7 | 10.5% | +11% | 8% | 9% |
| FOXF | 0.6 | — | 0.8 | — | 2.0% | +2% | -18% | -19% |
| MLR | 0.6 | 41.2 | 0.7 | 14.3 | 19.3% | -21% | 3% | 4% |
| Median of these 10 | 18.1 | 0.7 | 7.4 | 9.5% | +6% | 3% | 5% |
P/E 21.9 vs. a peer median of 18.1; EV/Sales 2.3 vs. 0.7. XPEL's own P/E sits at the 18th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesGT and DCH and FOXF have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
XPEL, Inc. — questions
- What is XPEL, Inc.'s market cap?
- $1.2B.
- What is XPEL, Inc.'s P/E ratio?
- 21.9 on trailing twelve-month earnings to 2026-06-30.
- What is XPEL, Inc.'s price-to-sales ratio?
- 2.3.
Every figure on this page comes from XPEL, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.